| Kelly M Oberhelman, PA | |
|
1500 East Medical Center Dr, 3rd Floor Taubman Center Recp D, Ann Arbor, MI 48109-5362 | |
| (734) 647-5944 | |
| Not Available |
| Full Name | Kelly M Oberhelman |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 24 Years |
| Location | 1500 East Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003967811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 5601003394 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Thursday's bipartisan health summit ended with the partisan rift intact, increasing the possibility that President Barack Obama will try to unify Democrats to pass legislation without GOP support.
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH's Community Engagement Alliance (CEAL) Against COVID-19 Disparities.
St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.
Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has submitted the Marketing Authorization Application (MAA) for Rhucin for the treatment of acute attacks of Hereditary Angioedema (HAE) to the European Medicines Agency (EMEA).
More than half of long-term smokers and ex-smokers who are considered disease-free because they passed lung-function tests have respiratory-related impairments when more closely evaluated with lung imaging, walking and quality-of-life tests. Many of those people likely have the earliest stages of chronic obstructive pulmonary disease, an incurable progressive disease (COPD) that is the third leading cause of death in the United States.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly M Oberhelman, PA 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Kelly M Oberhelman, PA 1500 East Medical Center Dr, 3rd Floor Taubman Center Recp D, Ann Arbor, MI 48109-5362 Ph: (734) 647-5944 |
News Archive
Thursday's bipartisan health summit ended with the partisan rift intact, increasing the possibility that President Barack Obama will try to unify Democrats to pass legislation without GOP support.
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH's Community Engagement Alliance (CEAL) Against COVID-19 Disparities.
St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.
Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has submitted the Marketing Authorization Application (MAA) for Rhucin for the treatment of acute attacks of Hereditary Angioedema (HAE) to the European Medicines Agency (EMEA).
More than half of long-term smokers and ex-smokers who are considered disease-free because they passed lung-function tests have respiratory-related impairments when more closely evaluated with lung imaging, walking and quality-of-life tests. Many of those people likely have the earliest stages of chronic obstructive pulmonary disease, an incurable progressive disease (COPD) that is the third leading cause of death in the United States.
› Verified 8 days ago
Carrie Kraeger Porter, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-6666 | |
Mrs. Katherine Ann Mccormack, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Aubrey Lynn Boucher, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Center Recp F, Ann Arbor, MI 48109 Phone: 734-936-5738 | |
Ainslee Joy Rubino, MS, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Andrea Bell Kmiec, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Cindy Felcher, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Drive, 2nd Floor Taubman Center Recp A, Ann Arbor, MI 48109 Phone: 734-936-5850 |